Challenged Healthcare Sector Could Offer Value via VFLO

The healthcare sector has certainly been fraught with a myriad of challenges this year, but weakness in the sector could have investors looking for value-oriented plays. That, in turn, could positively affect value-focused funds like the VictoryShares Free Cash Flow ETF (VFLO).

While the general healthcare sector is experiencing challenges, certain names may shine above others. Cigna and Merck are two companies to watch — both part of VFLO’s top 10 holdings. VFLO tracks the Victory U.S. Large Cap Free Cash Flow Index (the Index), and inclusion hinges upon a company’s expected free cash flow (a forward-looking measure of a company’s future cash flows), rather than solely relying on past data from trailing cash flow figures. The result is a more targeted focus on whether a company can continue growing its cash flow operations minus capital expenditures. The Index screens in companies that are relatively undervalued with attractive growth prospects, especially those in the healthcare sector, which already attracts bargain hunters.

Value in a Challenged Industry

During the height of the pandemic, healthcare stocks were strong performers until the tail end of 2021 when the bullish momentum began to fade. Since then, the sector has been marred by regulatory scrutiny as well as high costs, but a McKinsey & Company report noted that tailwinds such as pharmaceutical and healthcare delivery innovations could position the sector for a comeback.

By focusing on FCF, the index that VFLO seeks to track (before fees and expenses) has been able to identify names in the healthcare sector that appear primed for investment.

A Value Complement to Growth

In today’s market, it’s difficult to ignore the strength of growth and momentum factors. However, reviewing opportunities across the healthcare spectrum is a reminder that value investing strategies haven’t fallen to the wayside.

That said, investors can always use VFLO as a complement to a portfolio that’s already exposed to growth-fueled names in big tech. This can help provide investors with opportunities they wouldn’t otherwise get if too heavily concentrated in mega-cap technology companies.

For more news, information, and analysis, visit the Free Cash Flow Content Hub.